ANXA2P2 and cervical cancer: Research has revealed a regulatory loop involving the SRY-box transcription factor 9 (SOX9) gene/lncRNA annexin A2 pseudogene 2 (ANXA2P2)/miR-361-3p/SOX9 regulatory axis, which impacts cell growth and resistance to the chemotherapeutic drug cisplatin in cervical cancer.190